Soluble isoforms of vascular endothelial growth factor are predictors of response to sunitinib in metastatic renal cell carcinomas.

Abstract : BACKGROUND: Angiogenesis is the target of several agents in the treatment of malignancies, including renal cell carcinoma (RCC). There is a real need for surrogate biomarkers that can predict selection of patients who may benefit from antiangiogenic therapies, prediction of disease outcome and which may improve the knowledge regarding mechanism of action of these treatments. Tyrosine kinase inhibitors (TKI) have proven efficacy in metastatic RCC (mRCC). However, the molecular mechanisms underlying the clinical response to these drugs remain unclear. METHODOLOGY/PRINCIPAL FINDINGS: The present study aimed to identify molecular biomarkers associated with the response to sunitinib, a Tyrosine kinase inhibitor. To evaluate this relationship, primary tumors from 23 metastatic RCC patients treated by sunitinib were analyzed for a panel of 16 biomarkers involved in tumor pathways targeted by sunitinib, using real-time quantitative reverse-transcriptase PCR. Nine of the 23 patients (39%) responded to sunitinib. Among transcripts analyzed, only the levels of vascular endothelial growth factor (VEGF) soluble isoforms (VEGF(121) and VEGF(165)) were associated with the response to sunitinib (P = 0.04 for both). Furthermore, the ratio of VEGF soluble isoforms (VEGF(121)/VEGF(165)) was significantly associated with prognosis (P = 0.02). CONCLUSIONS: This preliminary study provides a promising tool that might help in the management of metastatic RCC, and could be extended to other tumors treated by TKI.
Type de document :
Article dans une revue
PLoS ONE, Public Library of Science, 2010, 5 (5), pp.e10715. 〈10.1371/journal.pone.0010715〉
Liste complète des métadonnées

Littérature citée [12 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-00490677
Contributeur : Georges Guellaen <>
Soumis le : mercredi 9 juin 2010 - 10:10:52
Dernière modification le : jeudi 15 mars 2018 - 10:12:30
Document(s) archivé(s) le : vendredi 17 septembre 2010 - 13:01:48

Fichier

pone.0010715.pdf
Fichiers éditeurs autorisés sur une archive ouverte

Identifiants

Collections

Citation

Bernard Paule, Laurence Bastien, Emmanuelle Deslandes, Olivier Cussenot, Marie-Pierre Podgorniak, et al.. Soluble isoforms of vascular endothelial growth factor are predictors of response to sunitinib in metastatic renal cell carcinomas.. PLoS ONE, Public Library of Science, 2010, 5 (5), pp.e10715. 〈10.1371/journal.pone.0010715〉. 〈inserm-00490677〉

Partager

Métriques

Consultations de la notice

483

Téléchargements de fichiers

248